Paromomycin, also known as aminosidine or Humatin, is an aminoglycoside antibiotic recognized for its potent anti-parasitic properties. Broadly used to treat acute and chronic intestinal amebiasis, Paromomycin works by eliminating parasites in the stomach and bowels causing infections. Furthermore, and importantly, it is utilized alongside other medications to alleviate symptoms associated with hepatic coma, a life-threatening complication of liver diseases. Paromomycin inhibits protein synthesis in parasites, which hampers their growth and ultimately results in their termination. Additionally, this antibiotic specifically targets ribosomes within parasitic cells, making it preferentially toxic to them and comparatively less harmful to the host cells.
Parent: Neomycin / Framycetin / Paromomycin
Parent: Neomycin/ Framycetin / Paromomycin
Parent: Paromomycin
As an antibiotic, and a pharmaceutical product, Paromomycin inherently possesses impurities and related compounds due to the complex production processes. These typically include derivatives arising from its synthesis, degradation products, and potential unknown entities. As per the guidelines set forward by regulatory authorities such as the ICH, these impurities are quantitatively analyzed and scrutinized to ensure the overall quality, safety, and efficacy of Paromomycin. It is critical to periodically carry out impurity profiling to identify, quantify, and keep these impurities under the permissible thresholds for safeguarding patient health.
Paromomycin is often given in conjunction with metronidazole to boost treatment effectiveness. Metronidazole is an antibiotic that stops the growth of certain bacteria and parasites. The combination therapy allows a broader spectrum of activity and increased efficacy against the parasites.
Paromomycin works by binding to the 30S ribosomal unit of the parasites, thereby preventing the initiation of protein synthesis. This activity ultimately hinders the growth and survival of the parasite leading to its death.
Paromomycin is also known as aminosidine. In the market, it’s sold under the brand name Humatin.
The safety of paromomycin in pregnancy has not been definitively established. As such, it should only be used if the potential benefits to the mother outweigh the possible risks to the fetus. It is important to consult a healthcare provider before taking it if you are pregnant or planning to become pregnant.
